On the basis of the previous discussions regarding siRNA delivery systems, the present study possibly provides an important target strategy involving 2′-O-methyl-modified siRNA targeting PECAM-1 using cationic lipids RNAi-mate against the proliferation of lung carcinoma cells (20,22,23). This evidence concerns the gene PECAM1 and lung carcinoma.